KURA
Kura Oncology, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.2% ·
aandelenstroom +5.9% ·
netto nieuwe posities -6.7%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +3 | 46.85M | $513.57M | +7 | −4 |
| Q1 2026 | 85 | 0 | 43.54M | $354.05M | +5 | −5 |
| Q4 2025 | 85 | 0 | 47.00M | $488.20M | +1 | −1 |
| Q3 2025 | 15 | -1 | 31.70M | $280.57M | — | −1 |
| Q2 2025 | 13 | 0 | 25.43M | $146.75M | — | — |
| Q1 2025 | 10 | 0 | 9.58M | $63.25M | — | — |
| Q4 2024 | 10 | -1 | 11.52M | $100.37M | +1 | −2 |
| Q3 2024 | 10 | 0 | 4.92M | $96.24M | +1 | −1 |
| Q2 2024 | 10 | — | 4.04M | $83.12M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 9.52M | +0.5% | $84.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 5.47M | +2.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 5.47M | +2.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 5.47M | +2.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 5.47M | +2.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 5.47M | +2.2% | $48.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 3.34M | +10.1% | $29.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Goldman Sachs Group ✦ | 2.61M | — | $23.14M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 2.61M | — | $23.14M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 2.24M | +138.1% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 2.24M | +138.1% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 2.24M | +138.1% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 2.24M | +138.1% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 2.24M | +138.1% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Millennium Management ✦ | 2.09M | -20.1% | $18.53M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 2.05M | +1.7% | $18.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Geode Capital Management ✦ (passief) | 2.05M | +1.7% | $18.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 1.81M | — | $16.05M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Renaissance Technologies ✦ | 865.31K | -18.1% | $7.66M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 808.82K | +122.1% | $7.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 808.82K | +122.1% | $7.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Marshall Wace ✦ | 488.75K | +1053.7% | $4.33M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | Marshall Wace ✦ | 488.75K | +1053.7% | $4.33M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 44 | Two Sigma Investments ✦ | 204.72K | -34.0% | $1.81M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 86.87K | +92.2% | $768,836 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 86.87K | +92.2% | $768,836 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 68.07K | — | $602,438 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | T. Rowe Price ✦ | 41.96K | +6.0% | $372,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| D. E. Shaw & Co. | $811,914 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 217 houders, 84.35M aandelen, $677.88M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · President and CEO · 100.00K aand @ 12.39 · $1.24M
Officer, Director · President and CEO · 100.00K aand @ 11.12 · $1.11M
Open-market verkopen (S)
Officer · 4.34K aand · $51,663
Officer · 31.49K aand · $397,681
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie